-
The characteristics of the included participants are described in Table 1. A total of 180,208 participants from CNHS (2015) were included in this study, with 84,449 (46.9%) males and 95,759 (53.1%) females. Among the participants, 73,818 lived in an urban area and 106,390 participants lived in a rural area. The number of participants from eastern, central, and western China was similar. Approximately one-third of the participants were ≥ 60 years of age. The majority of households (72.9%) sampled had an annual income > 100,000 CNY. Approximately 50% of the participants were in the low education group.
Table 1. Demographic characteristics of the participants
Characteristics N % National 180,208 100.0 Gender Male 84,449 46.9 Female 95,759 53.1 Residence Urban 73,818 41.0 Rural 106,390 59.0 Area East 67,732 37.6 Central 51,978 28.8 West 60,498 33.6 Age (years) 18–29 15,580 8.7 30–39 21,541 12.0 40–49 39,850 22.1 50–59 44,137 24.5 60– 59,100 32.8 Household Income Low 13,264 7.4 Middle 35,605 19.8 High 131,339 72.9 Education Low 88,034 48.9 Moderate 55,293 30.7 High 36,881 20.5 Table 2 shows the overall status of SUA levels in the different subgroups. The national SUA level of China in 2015 was 310.4 μmol/L. The levels of SUA in males were higher than females. Participants living in urban areas had slightly higher levels of SUV than participants living in rural areas. When considering the regional differences, the SUA levels of participants in central China were the lowest. Moreover, the highest SUA levels were observed in participants 18–29 years of age and in the highest education group. In addition, the SUA level increased as the household annual income increased.
Table 2. The levels of SUA in Chinese adults in 2015 (μmol/L)
Characteristics Mean SE P25 P50 P75 P National 310.4 2.0 246.5 299.9 364.3 Gender Male 351.8 2.4 291.9 344.3 404.2 < 0.0001 Female 268.4 1.6 220.8 260.0 307.0 Residence Urban 317.5 2.9 251.9 306.5 373.0 < 0.0001 Rural 302.9 2.1 240.8 292.6 353.9 Region East 315.5 3.7 250.0 305.0 370.8 < 0.0001 Central 303.5 2.3 241.7 292.5 354.1 West 310.4 2.7 246.0 300.8 363.5 Age (years) 18–29 319.2 2.7 252.0 308.3 376.4 < 0.0001 30–39 309.5 1.9 243.0 298.9 365.8 40–49 304.2 2.5 239.6 293.0 357.7 50–59 306.3 1.8 246.1 295.9 356.0 60– 311.0 1.9 250.6 301.2 360.2 Household Income Low 306.3 1.7 243.0 296.2 358.9 < 0.0001 Middle 316.8 3.0 250.8 305.9 371.7 High 322.4 2.8 257.2 312.9 377.8 Education Low 298.1 1.9 236.9 286.9 348.3 < 0.0001 Moderate 311.2 1.8 247.1 301.9 364.4 High 323.2 2.6 257.4 312.5 380.0 Table 3 compares the differences in SUA levels between urban and rural participants. The mean and median levels of SUA in each subgroup were all significantly higher in the urban population than the rural population, with the exception of the high education group. The trends in SUA levels in each urban and rural subgroup were also consistent. Table 4 presents the status of SUA levels among the three regions. Significant differences in SUA levels were observed in all subgroups among the eastern, central, and western China regions. The SUA levels in the central China region were lower than the other regions, and this trend was detected in each subgroup.
Table 3. The levels of SUA in city and rural in 2015 (μmol/L)
Characteristics Urban Rural P Mean SE P25 P50 P75 Mean SE P25 P50 P75 Gender Male 361.3 3.5 301.3 355.2 413.2 341.6 2.4 283.0 333.1 391.5 < 0.0001 Female 272.6 2.3 225.9 264.1 310.1 264.1 1.8 215.9 255.2 303.7 < 0.0001 Age (years) 18–29 323.4 4.1 253.1 311.6 383.1 314.0 2.7 250.7 305.2 367.7 0.0046 30–39 316.0 2.5 249.0 304.9 373.9 301.2 2.2 237.9 292.0 353.9 < 0.0001 40–49 312.9 3.9 246.2 302.9 369.0 295.1 2.3 232.0 284.1 345.0 < 0.0001 50–59 314.3 2.5 253.2 304.7 365.6 298.9 2.2 240.3 288.6 346.5 < 0.0001 60– 319.4 2.5 259.8 309.9 368.9 304.3 2.6 244.1 294.2 353.0 < 0.0001 Household Income Low 314.0 2.5 249.0 303.8 368.5 300.6 2.1 239.0 290.5 351.4 < 0.0001 Middle 320.8 3.9 253.8 309.1 377.9 308.4 2.4 246.0 297.2 357.5 < 0.0001 High 323.4 3.6 260.1 313.2 379.8 319.6 3.5 252.4 311.9 372.0 < 0.0001 Education Low 304.9 3.0 243.0 294.0 357.2 294.7 2.3 234.0 283.9 343.9 < 0.0001 Moderate 316.1 2.6 250.1 305.7 370.7 307.0 2.4 244.5 298.8 358.3 < 0.0001 High 324.4 3.3 257.9 313.7 382.0 319.2 2.8 255.9 309.9 371.3 0.7826 Table 4. The levels of SUA in east, middle, and west regions in 2015 (μmol/L)
Characteristics East Central West P Mean SE P25 P50 P75 Mean SE P25 P50 P75 Mean SE P25 P50 P75 Gender Male 358.8 4.5 298.4 352.5 411.5 343.4 2.9 285.2 335.0 393.9 350.3 3.0 290.5 342.1 402.9 < 0.0001 Female 271.5 2.7 224.7 262.8 310.9 263.8 2.1 217.0 256.2 301.6 268.9 2.7 220.3 260.3 308.9 < 0.0001 Age (years) 18–29 325.2 4.6 255.7 314.2 385.8 309.3 3.5 245.7 298.1 360.0 320.6 4.0 251.1 311.6 379.5 < 0.0001 30–39 314.9 3.4 246.2 304.9 370.0 302.4 2.5 239.1 290.9 357.6 309.3 2.7 244.0 301.0 365.0 < 0.0001 40–49 310.0 5.1 243.0 299.0 367.3 297.2 2.6 233.9 285.6 346.8 303.6 2.8 240.2 293.6 354.0 < 0.0001 50–59 309.6 3.3 249.1 299.9 361.0 302.3 2.6 243.4 291.4 350.4 305.7 2.7 245.3 295.4 354.0 < 0.0001 60– 314.5 3.6 253.5 305.0 366.5 306.6 3.0 247.5 297.0 353.4 310.7 3.0 250.0 300.9 360.1 < 0.0001 Household Income Low 310.1 3.4 245.4 299.4 364.8 300.4 2.3 239.4 290.0 349.7 308.0 2.8 244.6 299.0 361.2 < 0.0001 Middle 321.7 5.0 253.4 311.0 378.7 308.3 3.2 246.0 296.1 361.3 317.8 3.2 252.0 306.6 370.4 < 0.0001 High 324.1 3.9 260.7 316.5 379.9 317.8 3.5 255.2 307.0 370.6 321.6 5.7 251.0 310.3 377.0 < 0.0001 Education Low 301.8 3.9 239.1 291.0 355.0 292.2 2.4 233.2 281.4 338.5 299.9 2.9 239.0 288.9 350.6 < 0.0001 Moderate 314.6 3.3 249.0 304.0 369.1 305.1 2.4 243.6 295.8 355.0 313.8 3.0 250.0 305.5 366.7 < 0.0001 High 326.3 4.4 259.2 316.9 384.9 315.8 3.2 253.9 304.4 370.9 325.9 3.4 257.9 316.0 381.4 < 0.0001 Table 5 shows the prevalence of HUA in Chinese adults during 2015. The overall prevalence of HUA was 14.6%. The gender-specific prevalence of HUA was 19.5% in males and 9.6% in females. The lowest prevalence of HUA was observed in the central China region (12.5%). The highest prevalence of HUA was observed in participants 18–29 years of age (16.9%), followed by participants ≥ 60 years of age (15.2%). In the high-income family group, the prevalence of HUA was 17.4%, which was the highest among all family income groups. The high education group had a higher HUA prevalence; the trends were consistent with the SUA levels.
Table 5. The prevalence of HUA in Chinese adults in 2015*
Characteristics N % 95% CI χ2 P National 24,524 14.6 13.4−15.8 Gender Male 14,705 19.5 17.9−21.1 577.2078 < 0.0001 Female 9,819 9.6 8.7−10.5 Residence Urban 11,300 16.5 14.6−18.4 17.6736 < 0.0001 Rural 13,224 12.5 11.5−13.6 Region East 10,426 16.0 13.7−18.3 8.9343 0.0115 Central 6,262 12.5 11.2−13.8 West 7,836 14.8 13.2−16.4 Age (years) 18–29 2,404 16.9 15.1−18.6 46.1217 < 0.0001 30–39 2,770 14.1 12.9−15.3 40–49 4,568 13.2 11.4−15.1 50–59 5,643 13.0 12.0−14.0 60– 9,139 15.2 14.1−16.3 Household Income Low 2,171 13.6 12.6−14.6 48.9419 < 0.0001 Middle 5,378 16.2 14.4−18.0 High 16,975 17.4 15.5−19.2 Education Low 11,439 12.7 11.7−13.7 102.7242 < 0.0001 Moderate 7,421 14.2 12.9−15.5 High 5,664 17.1 15.5−18.7 Note. *The prevalence of HUA was weighted. In the comparison between urban and rural areas shown in Table 6, significant differences in the prevalence of HUA were observed in gender, age, and household income subgroups; however, there were no statistically significant differences in the prevalence of HUA between urban and rural women, the 18–29-year age group, and the high household income subgroup. Furthermore, we also compared the differences in prevalence of HUA among the eastern, central, and western regions of China (Table 7). Among the three regions, no significant differences in HUA prevalence were observed in the female subgroups. Although there were significant differences in SUA levels across age groups, the significant differences in HUA prevalence among age groups disappeared with increasing age. Interestingly, in the 18–29-year age group, the highest prevalence of HUA (19.03%) occurred in the western China region, while in the 30–39-year age group, the highest prevalence of HUA was observed in the eastern China region. Among the eastern, central, and western China regions, only the low-income family group showed significant differences, and the prevalence of HUA in the eastern China region of this subgroup was 14.9%. There was a significant difference in the prevalence of HUA between the low- and intermediate-level groups; however, no significant difference existed in the higher education subgroup.
Table 6. The prevalence of HUA in city and rural in 2015*
Characteristics Urban Rural χ2 P % 95% CI % 95% CI Gender Male 22.5 20.0−24.9 16.3 14.9−17.6 27.4594 < 0.0001 Female 10.4 8.9−11.9 8.8 7.9−9.7 3.6450 0.0562 Age (years) 18–29 17.7 15.0−20.4 15.8 14.0−17.6 1.4492 0.2287 30–39 16.2 14.7−17.8 11.3 10.2−12.4 41.3067 < 0.0001 40–49 15.7 12.5−18.9 10.7 9.5−11.9 12.1952 0.0005 50–59 15.0 13.5−16.6 11.2 10.0−12.3 18.4398 < 0.0001 60– 17.5 15.9−19.1 13.3 11.9−14.7 15.3478 < 0.0001 Household Income Low 15.7 13.9−17.5 12.1 11.0−13.1 0.1971 0.0002 Middle 17.4 15.0−19.8 13.5 12.1−14.9 10.5816 0.0011 High 17.6 15.3−19.8 16.8 14.2−19.4 13.5363 0.6571 Education Low 14.3 12.3−16.3 11.9 10.8−13.0 4.8211 0.0281 Moderate 16.2 14.0−18.5 12.5 11.2−13.7 10.3297 0.0013 High 17.8 15.9−19.7 14.9 13.0−16.7 5.1428 0.0233 Note. *The prevalence of HUA was weighted. Table 7. The prevalence of HUA in east, middle, and west regions in 2015*
Characteristics East Central West χ2 P % 95% CI % 95% CI % 95% CI Gender Male 21.4 18.5−24.4 16.8 14.8−18.8 19.5 17.5−21.6 8.6436 0.0133 Female 10.5 8.7−12.2 8.3 7.3−9.2 9.9 8.4−11.3 5.7156 0.0574 Age (years) 18–29 17.9 15.0−20.8 13.5 11.3−15.7 19.0 16.1−22.0 8.8743 0.0118 30–39 15.8 13.9−17.7 12.2 10.3−14.2 13.6 11.9−15.3 8.3471 0.0154 40–49 15.3 11.2−19.3 11.3 9.7−12.8 12.5 11.0−14.0 5.9851 0.0502 50–59 13.9 12.1−15.7 12.0 10.5−13.4 12.9 11.2−14.5 3.0044 0.2226 60– 16.3 14.3−18.4 13.7 11.9−15.4 15.2 13.4−17.0 4.4096 0.1103 Household Income Low 14.9 12.7−17.1 11.7 10.5−12.9 14.1 12.5−15.7 8.1885 0.0167 Middle 17.3 14.3−20.3 14.0 11.7−16.3 16.7 14.8−18.7 4.6098 0.0998 High 17.6 15.0−20.1 15.9 13.3−18.5 18.8 14.8−22.8 1.3901 0.4990 Education Low 14.1 11.8−16.3 11.2 10.0−12.3 12.7 11.2−14.2 6.0618 0.0483 Moderate 15.6 13.0−18.1 12.1 10.6−13.5 14.8 13.0−16.6 7.4313 0.0243 High 17.8 15.2−20.3 14.7 12.6−16.9 18.8 16.4−21.2 5.3781 0.0679 Note. *The prevalence of HUA was weighted.
doi: 10.3967/bes2022.118
Status of Serum Uric Acid and Hyperuricemia among Adults in China: China Nutrition and Health Surveillance (2015)
-
Abstract:
Objective The purpose of this study was to determine the serum uric acid levels and the prevalence of hyperuricemia among Chinese adults in 2015 and compare the differences between urban and rural areas, as well as the differences between eastern, central, and western regions. Methods A national representative sample of 180,208 participants were included using a stratified, multistage, and random sampling method. The demographic characteristics and blood samples were collected to determine the serum uric acid levels and prevalence of hyperuricemia among subgroups using complicated sampling weight. A t-test or ANOVA was used for normally-distributed data. The Kruskal-Wallis rank test was used for skewed-distributed data. The Mantel-Haenszel chi-square test was used to compare the difference in categorical variables. Results The weighted mean uric acid level in Chinese adults was 310.4 μmol/L (317.5 μmol/L in urban areas and 302.9 μmol/L in rural areas). The weighted average values of uric acid in eastern, central, and western China were 315.5 μmol/L, 303.5 μmol/L, and 310.4 μmol/L, respectively. The weighted prevalence of hyperuricemia in Chinese adults was 14.6%, with a prevalence of 16.5% in urban areas and 12.5% in rural areas. The weighted prevalence of hyperuricemia in eastern, central, and western China was 16.0%, 12.5%, and 14.8%, respectively. Conclusion The uric acid level in Chinese adults is relatively high. Effective actions are warranted to improve this metabolic abnormality. -
Key words:
- Uric acid /
- Hyperuricemia /
- Adults /
- China
-
Table 1. Demographic characteristics of the participants
Characteristics N % National 180,208 100.0 Gender Male 84,449 46.9 Female 95,759 53.1 Residence Urban 73,818 41.0 Rural 106,390 59.0 Area East 67,732 37.6 Central 51,978 28.8 West 60,498 33.6 Age (years) 18–29 15,580 8.7 30–39 21,541 12.0 40–49 39,850 22.1 50–59 44,137 24.5 60– 59,100 32.8 Household Income Low 13,264 7.4 Middle 35,605 19.8 High 131,339 72.9 Education Low 88,034 48.9 Moderate 55,293 30.7 High 36,881 20.5 Table 2. The levels of SUA in Chinese adults in 2015 (μmol/L)
Characteristics Mean SE P25 P50 P75 P National 310.4 2.0 246.5 299.9 364.3 Gender Male 351.8 2.4 291.9 344.3 404.2 < 0.0001 Female 268.4 1.6 220.8 260.0 307.0 Residence Urban 317.5 2.9 251.9 306.5 373.0 < 0.0001 Rural 302.9 2.1 240.8 292.6 353.9 Region East 315.5 3.7 250.0 305.0 370.8 < 0.0001 Central 303.5 2.3 241.7 292.5 354.1 West 310.4 2.7 246.0 300.8 363.5 Age (years) 18–29 319.2 2.7 252.0 308.3 376.4 < 0.0001 30–39 309.5 1.9 243.0 298.9 365.8 40–49 304.2 2.5 239.6 293.0 357.7 50–59 306.3 1.8 246.1 295.9 356.0 60– 311.0 1.9 250.6 301.2 360.2 Household Income Low 306.3 1.7 243.0 296.2 358.9 < 0.0001 Middle 316.8 3.0 250.8 305.9 371.7 High 322.4 2.8 257.2 312.9 377.8 Education Low 298.1 1.9 236.9 286.9 348.3 < 0.0001 Moderate 311.2 1.8 247.1 301.9 364.4 High 323.2 2.6 257.4 312.5 380.0 Table 3. The levels of SUA in city and rural in 2015 (μmol/L)
Characteristics Urban Rural P Mean SE P25 P50 P75 Mean SE P25 P50 P75 Gender Male 361.3 3.5 301.3 355.2 413.2 341.6 2.4 283.0 333.1 391.5 < 0.0001 Female 272.6 2.3 225.9 264.1 310.1 264.1 1.8 215.9 255.2 303.7 < 0.0001 Age (years) 18–29 323.4 4.1 253.1 311.6 383.1 314.0 2.7 250.7 305.2 367.7 0.0046 30–39 316.0 2.5 249.0 304.9 373.9 301.2 2.2 237.9 292.0 353.9 < 0.0001 40–49 312.9 3.9 246.2 302.9 369.0 295.1 2.3 232.0 284.1 345.0 < 0.0001 50–59 314.3 2.5 253.2 304.7 365.6 298.9 2.2 240.3 288.6 346.5 < 0.0001 60– 319.4 2.5 259.8 309.9 368.9 304.3 2.6 244.1 294.2 353.0 < 0.0001 Household Income Low 314.0 2.5 249.0 303.8 368.5 300.6 2.1 239.0 290.5 351.4 < 0.0001 Middle 320.8 3.9 253.8 309.1 377.9 308.4 2.4 246.0 297.2 357.5 < 0.0001 High 323.4 3.6 260.1 313.2 379.8 319.6 3.5 252.4 311.9 372.0 < 0.0001 Education Low 304.9 3.0 243.0 294.0 357.2 294.7 2.3 234.0 283.9 343.9 < 0.0001 Moderate 316.1 2.6 250.1 305.7 370.7 307.0 2.4 244.5 298.8 358.3 < 0.0001 High 324.4 3.3 257.9 313.7 382.0 319.2 2.8 255.9 309.9 371.3 0.7826 Table 4. The levels of SUA in east, middle, and west regions in 2015 (μmol/L)
Characteristics East Central West P Mean SE P25 P50 P75 Mean SE P25 P50 P75 Mean SE P25 P50 P75 Gender Male 358.8 4.5 298.4 352.5 411.5 343.4 2.9 285.2 335.0 393.9 350.3 3.0 290.5 342.1 402.9 < 0.0001 Female 271.5 2.7 224.7 262.8 310.9 263.8 2.1 217.0 256.2 301.6 268.9 2.7 220.3 260.3 308.9 < 0.0001 Age (years) 18–29 325.2 4.6 255.7 314.2 385.8 309.3 3.5 245.7 298.1 360.0 320.6 4.0 251.1 311.6 379.5 < 0.0001 30–39 314.9 3.4 246.2 304.9 370.0 302.4 2.5 239.1 290.9 357.6 309.3 2.7 244.0 301.0 365.0 < 0.0001 40–49 310.0 5.1 243.0 299.0 367.3 297.2 2.6 233.9 285.6 346.8 303.6 2.8 240.2 293.6 354.0 < 0.0001 50–59 309.6 3.3 249.1 299.9 361.0 302.3 2.6 243.4 291.4 350.4 305.7 2.7 245.3 295.4 354.0 < 0.0001 60– 314.5 3.6 253.5 305.0 366.5 306.6 3.0 247.5 297.0 353.4 310.7 3.0 250.0 300.9 360.1 < 0.0001 Household Income Low 310.1 3.4 245.4 299.4 364.8 300.4 2.3 239.4 290.0 349.7 308.0 2.8 244.6 299.0 361.2 < 0.0001 Middle 321.7 5.0 253.4 311.0 378.7 308.3 3.2 246.0 296.1 361.3 317.8 3.2 252.0 306.6 370.4 < 0.0001 High 324.1 3.9 260.7 316.5 379.9 317.8 3.5 255.2 307.0 370.6 321.6 5.7 251.0 310.3 377.0 < 0.0001 Education Low 301.8 3.9 239.1 291.0 355.0 292.2 2.4 233.2 281.4 338.5 299.9 2.9 239.0 288.9 350.6 < 0.0001 Moderate 314.6 3.3 249.0 304.0 369.1 305.1 2.4 243.6 295.8 355.0 313.8 3.0 250.0 305.5 366.7 < 0.0001 High 326.3 4.4 259.2 316.9 384.9 315.8 3.2 253.9 304.4 370.9 325.9 3.4 257.9 316.0 381.4 < 0.0001 Table 5. The prevalence of HUA in Chinese adults in 2015*
Characteristics N % 95% CI χ2 P National 24,524 14.6 13.4−15.8 Gender Male 14,705 19.5 17.9−21.1 577.2078 < 0.0001 Female 9,819 9.6 8.7−10.5 Residence Urban 11,300 16.5 14.6−18.4 17.6736 < 0.0001 Rural 13,224 12.5 11.5−13.6 Region East 10,426 16.0 13.7−18.3 8.9343 0.0115 Central 6,262 12.5 11.2−13.8 West 7,836 14.8 13.2−16.4 Age (years) 18–29 2,404 16.9 15.1−18.6 46.1217 < 0.0001 30–39 2,770 14.1 12.9−15.3 40–49 4,568 13.2 11.4−15.1 50–59 5,643 13.0 12.0−14.0 60– 9,139 15.2 14.1−16.3 Household Income Low 2,171 13.6 12.6−14.6 48.9419 < 0.0001 Middle 5,378 16.2 14.4−18.0 High 16,975 17.4 15.5−19.2 Education Low 11,439 12.7 11.7−13.7 102.7242 < 0.0001 Moderate 7,421 14.2 12.9−15.5 High 5,664 17.1 15.5−18.7 Note. *The prevalence of HUA was weighted. Table 6. The prevalence of HUA in city and rural in 2015*
Characteristics Urban Rural χ2 P % 95% CI % 95% CI Gender Male 22.5 20.0−24.9 16.3 14.9−17.6 27.4594 < 0.0001 Female 10.4 8.9−11.9 8.8 7.9−9.7 3.6450 0.0562 Age (years) 18–29 17.7 15.0−20.4 15.8 14.0−17.6 1.4492 0.2287 30–39 16.2 14.7−17.8 11.3 10.2−12.4 41.3067 < 0.0001 40–49 15.7 12.5−18.9 10.7 9.5−11.9 12.1952 0.0005 50–59 15.0 13.5−16.6 11.2 10.0−12.3 18.4398 < 0.0001 60– 17.5 15.9−19.1 13.3 11.9−14.7 15.3478 < 0.0001 Household Income Low 15.7 13.9−17.5 12.1 11.0−13.1 0.1971 0.0002 Middle 17.4 15.0−19.8 13.5 12.1−14.9 10.5816 0.0011 High 17.6 15.3−19.8 16.8 14.2−19.4 13.5363 0.6571 Education Low 14.3 12.3−16.3 11.9 10.8−13.0 4.8211 0.0281 Moderate 16.2 14.0−18.5 12.5 11.2−13.7 10.3297 0.0013 High 17.8 15.9−19.7 14.9 13.0−16.7 5.1428 0.0233 Note. *The prevalence of HUA was weighted. Table 7. The prevalence of HUA in east, middle, and west regions in 2015*
Characteristics East Central West χ2 P % 95% CI % 95% CI % 95% CI Gender Male 21.4 18.5−24.4 16.8 14.8−18.8 19.5 17.5−21.6 8.6436 0.0133 Female 10.5 8.7−12.2 8.3 7.3−9.2 9.9 8.4−11.3 5.7156 0.0574 Age (years) 18–29 17.9 15.0−20.8 13.5 11.3−15.7 19.0 16.1−22.0 8.8743 0.0118 30–39 15.8 13.9−17.7 12.2 10.3−14.2 13.6 11.9−15.3 8.3471 0.0154 40–49 15.3 11.2−19.3 11.3 9.7−12.8 12.5 11.0−14.0 5.9851 0.0502 50–59 13.9 12.1−15.7 12.0 10.5−13.4 12.9 11.2−14.5 3.0044 0.2226 60– 16.3 14.3−18.4 13.7 11.9−15.4 15.2 13.4−17.0 4.4096 0.1103 Household Income Low 14.9 12.7−17.1 11.7 10.5−12.9 14.1 12.5−15.7 8.1885 0.0167 Middle 17.3 14.3−20.3 14.0 11.7−16.3 16.7 14.8−18.7 4.6098 0.0998 High 17.6 15.0−20.1 15.9 13.3−18.5 18.8 14.8−22.8 1.3901 0.4990 Education Low 14.1 11.8−16.3 11.2 10.0−12.3 12.7 11.2−14.2 6.0618 0.0483 Moderate 15.6 13.0−18.1 12.1 10.6−13.5 14.8 13.0−16.6 7.4313 0.0243 High 17.8 15.2−20.3 14.7 12.6−16.9 18.8 16.4−21.2 5.3781 0.0679 Note. *The prevalence of HUA was weighted. -
[1] Li M, Hou WS, Zhang XW, et al. Hyperuricemia and risk of stroke: a systematic review and meta-analysis of prospective studies. Atherosclerosis, 2014; 232, 265−70. doi: 10.1016/j.atherosclerosis.2013.11.051 [2] Vogt B. Urate oxidase (rasburicase) for treatment of severe tophaceous gout. Nephrol Dial Transplant, 2005; 20, 431−3. doi: 10.1093/ndt/gfh629 [3] Wang YG, Yan SL, Li CG, et al. Risk factors for gout developed from hyperuricemia in China: a five-year prospective cohort study. Rheumatol Int, 2013; 33, 705−10. doi: 10.1007/s00296-012-2439-8 [4] Liu R, Han C, Wu D, et al. Prevalence of hyperuricemia and gout in Mainland China from 2000 to 2014: A systematic review and meta-analysis. Biomed Res Int, 2015; 2015, 762820. [5] Bezerra TTD, Bezerra LS, Santos-Veloso MAO, et al. Association between hyperuricemia and hypertension: a case-control study. Rev Assoc Med Bras (1992), 2021; 67, 828−32. doi: 10.1590/1806-9282.20210021 [6] Shirasawa T, Ochiai H, Yoshimoto T, et al. Correction to: Cross-sectional study of associations between normal body weight with central obesity and hyperuricemia in Japan. BMC Endocr Disord, 2020; 20, 26. doi: 10.1186/s12902-020-0494-9 [7] Lu XX, Shi XG, Li YB, et al. A negative association between urinary iodine concentration and the prevalence of hyperuricemia and gout: a cross-sectional and population-based study in Mainland China. Eur J Nutr, 2020; 59, 3659−68. doi: 10.1007/s00394-020-02199-z [8] Sun P, Chen MQ, Guo XF, et al. Combined effect of hypertension and hyperuricemia on ischemic stroke in a rural Chinese population. BMC Public Health, 2021; 21, 776. doi: 10.1186/s12889-021-10858-x [9] Ali N, Miah R, Hasan M, et al. Association between serum uric acid and metabolic syndrome: a cross-sectional study in Bangladeshi adults. Sci Rep, 2020; 10, 7841. doi: 10.1038/s41598-020-64884-7 [10] Saito Y, Tanaka A, Node K, et al. Uric acid and cardiovascular disease: A clinical review. J Cardiol, 2021; 78, 51−7. doi: 10.1016/j.jjcc.2020.12.013 [11] Ae R, Kanbay M, Kuwabara M. The causality between the serum uric acid level and stroke. Hypertens Res, 2020; 43, 354−6. doi: 10.1038/s41440-019-0346-z [12] Song PG, Wang H, Xia W, et al. Prevalence and correlates of hyperuricemia in the middle-aged and older adults in China. Sci Rep, 2018; 8, 4314. doi: 10.1038/s41598-018-22570-9 [13] Ito S, Torii T, Nakajima A, et al. Prevalence of gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database. BMC Pediatr, 2020; 20, 481. doi: 10.1186/s12887-020-02379-0 [14] Arersa KK, Wondimnew T, Welde M, et al. Prevalence and determinants of hyperuricemia in type 2 diabetes mellitus patients attending Jimma Medical Center, Southwestern Ethiopia, 2019. Diabetes Metab Syndr Obes, 2020; 13, 2059−67. doi: 10.2147/DMSO.S252825 [15] Lee JH. Prevalence of hyperuricemia and its association with metabolic syndrome and cardiometabolic risk factors in Korean children and adolescents: analysis based on the 2016-2017 Korea National Health and Nutrition Examination Survey. Korean J Pediatr, 2019; 62, 317−23. doi: 10.3345/kjp.2019.00444 [16] Billa G, Dargad R, Mehta A. Prevalence of hyperuricemia in Indian subjects attending hyperuricemia screening programs-A retrospective study. J Assoc Physicians India, 2018; 66, 43−6. [17] Zhu YY, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum, 2011; 63, 3136−41. doi: 10.1002/art.30520 [18] Kim SK, Choe JY. Association between smoking and serum uric acid in Korean population. Medicine (Baltimore), 2019; 98, e14507. doi: 10.1097/MD.0000000000014507 [19] Nejatinamini S, Ataie-Jafari A, Qorbani M, et al. Association between serum uric acid level and metabolic syndrome components. J Diabetes Metab Disord, 2015; 14, 70. doi: 10.1186/s40200-015-0200-z [20] Guan SC, Tang Z, Fang XH, et al. Prevalence of hyperuricemia among Beijing post-menopausal women in 10 years. Arch Gerontol Geriatr, 2016; 64, 162−6. doi: 10.1016/j.archger.2016.02.002 [21] Huang XB, Zhang WQ, Tang WW, et al. Prevalence and associated factors of hyperuricemia among urban adults aged 35-79 years in southwestern China: a community-based cross-sectional study. Sci Rep, 2020; 10, 15683. doi: 10.1038/s41598-020-72780-3 [22] Liu B, Wang T, Zhao HN, et al. The prevalence of hyperuricemia in China: a meta-analysis. BMC Public Health, 2011; 11, 832. doi: 10.1186/1471-2458-11-832 [23] Yu DM, Zhao LY, Zhang J, et al. China nutrition and health surveys (1982-2017). China CDC Wkly, 2021; 3, 193−5. doi: 10.46234/ccdcw2021.058 [24] Su P, Hong L, Zhao YF, et al. Relationship between hyperuricemia and cardiovascular disease risk factors in a Chinese population: A cross-sectional study. Med Sci Monit, 2015; 21, 2707−17. doi: 10.12659/MSM.895448 [25] Ali N, Perveen R, Rahman S, et al. Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: A study on Bangladeshi adults. PLoS One, 2018; 13, e0206850. doi: 10.1371/journal.pone.0206850 [26] Liu H, Zhang XM, Wang YL, et al. Prevalence of hyperuricemia among Chinese adults: a national cross-sectional survey using multistage, stratified sampling. J Nephrol, 2014; 27, 653−8. doi: 10.1007/s40620-014-0082-z [27] Maloberti A, Qualliu E, Occhi L, et al. Hyperuricemia prevalence in healthy subjects and its relationship with cardiovascular target organ damage. Nutr Metab Cardiovasc Dis, 2021; 31, 178−85. doi: 10.1016/j.numecd.2020.08.015 [28] Sari I, Akar S, Pakoz B, et al. Hyperuricemia and its related factors in an urban population, Izmir, Turkey. Rheumatol Int, 2009; 29, 869−74. doi: 10.1007/s00296-008-0806-2 [29] Yu SS, Yang HM, Guo XF, et al. Prevalence of hyperuricemia and its correlates in rural Northeast Chinese population: from lifestyle risk factors to metabolic comorbidities. Clin Rheumatol, 2016; 35, 1207−15. doi: 10.1007/s10067-015-3051-6 [30] Lohsoonthorn V, Dhanamun B, Williams MA. Prevalence of hyperuricemia and its relationship with metabolic syndrome in Thai adults receiving annual health exams. Arch Med Res, 2006; 37, 883−9. doi: 10.1016/j.arcmed.2006.03.008 [31] Hak AE, Choi HK. Menopause, postmenopausal hormone use and serum uric acid levels in US women – The Third National Health and Nutrition Examination Survey. Arthritis Res Ther, 2008; 10, R116. doi: 10.1186/ar2519 [32] De Vera MA, Rahman MM, Bhole V, et al. Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study. Ann Rheum Dis, 2010; 69, 1162−4. doi: 10.1136/ard.2009.122770 [33] Roddy E, Zhang WY, Doherty M. The changing epidemiology of gout. Nat Clin Pract Rheumatol, 2007; 3, 443−9. [34] Cho SK, Winkler CA, Lee SJ, et al. The prevalence of hyperuricemia sharply increases from the late menopausal transition stage in middle-aged women. J Clin Med, 2019; 8, 296. doi: 10.3390/jcm8030296 [35] Gerber V, Goldbourt U, Drory Y, et al. Interaction between income and education in predicting long-term survival after acute myocardial infarction. Eur J Cardiovasc Prev Rehabil, 2008; 15, 526−32. doi: 10.1097/HJR.0b013e328304feac [36] Zhang LX, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet, 2012; 379, 815−22. doi: 10.1016/S0140-6736(12)60033-6 [37] Zuo H, Shi ZM, Hu XS, et al. Prevalence of metabolic syndrome and factors associated with its components in Chinese adults. Metabolism, 2009; 58, 1102−8. doi: 10.1016/j.metabol.2009.04.008 [38] Popkin BM, Du SF, Zhai FY, et al. Cohort Profile: The China Health and Nutrition Survey-monitoring and understanding socio-economic and health change in China, 1989-2011. Int J Epidemiol, 2010; 39, 1435−40. doi: 10.1093/ije/dyp322 [39] Choi HK, Atkinson K, Karlson EW, et al. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med, 2004; 350, 1093−103. doi: 10.1056/NEJMoa035700 [40] Winder M, Owczarek AJ, Mossakowska M, et al. Prevalence of hyperuricemia and the use of allopurinol in older poles-results from a population-based PolSenior study. Int J Environ Res Public Health, 2021; 18, 387. doi: 10.3390/ijerph18020387 [41] Yang BY, Mo ZN, Wu C, et al. A genome-wide association study identifies common variants influencing serum uric acid concentrations in a Chinese population. BMC Med Genomics, 2014; 7, 10. doi: 10.1186/1755-8794-7-10